Weller SC, Davis-Beaty K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003255. DOI: 10.1002/14651858.CD003255.
Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404.
Saracco A, Musicco M, Nicolosi A, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acq Immun Def Syndr 1993;6:497-502.
Minnis AM, Padian NS. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Sexually Transmitted Infections. 2005;81:193-200.
McNeill ET, Gilmore CE, Finger WR, et.al., The Latex Condom: Recent Advances, Future Directions. Durham, NC: FHI, 1996.
Holmes KK, et al. Effectiveness of condoms in preventing sexually transmitted infections. Bulletin of the World Health Organization, June 2004, 82(6).
Hatcher RA, Trussell J, Nelson AL, et al. Contraceptive Technology. Nineteenth Revised Edition. New York: Ardent Media, Inc., 2007.
FHI . Female Condom Research Brief Series—No. 2: Effectiveness for Preventing Pregnancy and Sexually Transmitted Infections. Durham, NC; FHI , 2007.
Female Health Company. Partner Communication and Negotiation Steps and Questions. Chicago; The Female Health Company, (no date).
EngenderHealth. Integration of HIV/STI prevention, sexuality and dual protection in family planning counseling: A training manual. New York; EngenderHealth, 2002.
Deschamps M-M, Pape JW, Hafner A, et al. Heterosexual transmission of HIV in Haiti. Ann Inter Med 1996;125:324-30
Davis K and Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Family Planning Perspectives. 1999; 31(6):272-279.
Condoms and HIV prevention: Position statement by UNAIDS, UNFPA and WHO. N.Y; UNAIDS, 2009
Bryden, D. Condom gap “quite disturbing” according to PEPFAR. Science Speaks: HIV and TB News. Washington, D.C.; Center for Global Health, 2011.
Boily MC, Baggaley RF, Wang L, Masse B, White RG, et.al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 2:118-129. DOI: 10.1016/S1473-3099(09)70021-0.
Beksinka M, Smit J, Joanis C, Usher-Patel M, Potter W. Female condom technology: new products and regulatory issues. Contraception 2011. 83(4):316-321.
World Health Organization, UNFPA and Family Health International. The male latex condom: Specification, prequalification and guidelines for procurement. Geneva: WHO, 2010.
Feldblum, PJ. Pregnancy and STD prevention. In McNeill ET, Gilmore CE, Finger WR, et.al. The Latex Condom: Recent Advances, Future Directions. Durham, NC: FHI.
Comprehensive Condom Programming: A Strategic Response to HIV and AIDS
The WHO Medical Eligibility Criteria Wheel for Contraceptive Use (2015
A tool that makes it easy to identify medical eligibility for use of family planning methods.
The Selected Practice Recommendations for Contraceptive Use (3rd Edition 2016).
This resource provides guidance on how to use contraceptive methods safely and effectively, once they are deemed to be medically appropriate.
The Medical Eligibility Criteria for Contraceptive Use (5th edition 2015).
This resource provides guidance on whether people with certain medical conditions can safely and effectively use specific contraceptive methods.
Family Planning: A Global Handbook for Providers (2022 update).
This book serves as a quick-reference resource for all level of health care workers. It provides practical guidance on delivering family planning methods appropriately and effectively.
